Skip to content

Respiratory Training in Patients With Leukemia

Influence of Respiratory Training on Functional Capacity in Patients With Leukemia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03876834
Enrollment
40
Registered
2019-03-15
Start date
2018-03-01
Completion date
2018-06-30
Last updated
2019-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia

Keywords

leukemia, chemotherapy, respiratory training

Brief summary

Forty male leukemic patients receiving chemotherapy were selected from National Cancer Institute, They were randomly assigned into two groups. Group (A) included 30 patients who were trained by Inspiratory muscle trainer for 4 weeks ;5 sessions/week and Group (B) included 10 patients as a control group. The following measures were taken before and after the study period : Maximum voluntary ventilation(MVV) , 2 min walk test, FACT-G questionnaire

Detailed description

Forty male leukemic patients receiving chemotherapy for at least one cycle and their mean ages 37.1 ± 4.89 years.The patients were selected from National Cancer Institute, Cairo ( inpatient ward). The study lasted from March 2018 to June 2018. Patients were randomly assigned into two groups.Group A (30 patients) who received inspiratory muscles training for 4 successive weeks, 5 sessions/week; and Group B (10 patients) acted as a control group on chemotherapy only. Data obtained from both groups regarding (MVV), 2 min walk test and Quality of life questionnaire (FACT-G) were statistically analyzed and compared

Interventions

Respiratory training was done by using threshold inspiratory muscle trainer(Respironics, New Jersey , USA, No.8373-0730)

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
30 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* male patient with age ranges from 30-50 years * All patients were leukemic receiving chemotherapy for at least one cycle as a treatment of malignant tumor * All patients were hemodynamically stable * All patients were ambulant

Exclusion criteria

* lung cancer * History of any pulmonary disease. * Metastasis of lungs, ribs, mediastinal structure * Pulmonary pathology(e.g acute respiratory distress syndrome or exacerbation of chronic obstructive pulmonary disease) * ruptured ear drum or any other condition of the ear * High peak airway pressure (barotraumas) * patients with marked elevated left ventricular end diastolic volume and pressure * patients with worsening heart failure signs and symptoms

Design outcomes

Primary

MeasureTime frameDescription
Maximum voluntary ventilationchange from baseline maximum voluntary ventilation at 4 weeksIt was performed by breathing deeply and rapidly for 10 to 15 seconds using spirometer
2 min walk testchange from baseline 2 min walk test at 4 weeksEach patient was asked to cover as much ground as possible over 2 minutes
FACT-G questionnairechange from baseline FACT-G questionnaire at 4 weeks27 questions with four domains assessing physical well being,social well being, emotional well being and functional wellbeing

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026